![](https://endpts.com/wp-content/uploads/2020/10/News_briefing_FE.jpg)
Abcam founder Jonathan Milner opposes Danaher buyout; First Wave tries to find new life in Sanofi drug
Abcam’s founder Jonathan Milner plans to vote against Danaher’s $5.7 billion acquisition of the company, he announced Thursday.
Milner owns …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.